Can GPR4 Be a Potential Therapeutic Target for COVID-19?

Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in late 2019 and has since rapidly become a global pandemic. SARS-CoV-2 infection causes damages to the lung and other organs. The clinical manifestations of COVID-19 range widely...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Li V., Oppelt, Karen A., Thomassen, Mary Jane, Marie, Mona A., Nik Akhtar, Shayan, McCallen, Justin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859652/
https://www.ncbi.nlm.nih.gov/pubmed/33553219
http://dx.doi.org/10.3389/fmed.2020.626796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859652/
https://www.ncbi.nlm.nih.gov/pubmed/33553219
http://dx.doi.org/10.3389/fmed.2020.626796

Ejemplares similares